Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
4.830
-0.340 (-6.58%)
At close: Apr 3, 2025, 4:00 PM
4.910
+0.080 (1.66%)
After-hours: Apr 3, 2025, 8:00 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Emergent BioSolutions stock have an average target of 14.33, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 196.69% from the current stock price of 4.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Emergent BioSolutions stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +210.56% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +210.56% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +210.56% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +210.56% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +210.56% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
833.25M
from 1.04B
Decreased by -20.16%
Revenue Next Year
998.89M
from 833.25M
Increased by 19.88%
EPS This Year
0.76
from -3.60
EPS Next Year
1.54
from 0.76
Increased by 102.67%
Revenue Forecast
| Revenue | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|
| High | 892.5M | 1.0B | 1.5B | |
| Avg | 833.3M | 998.9M | 1.5B | |
| Low | 784.0M | 969.2M | 1.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|
| High | -14.5% | 24.6% | 51.6% | |
| Avg | -20.2% | 19.9% | 45.8% | |
| Low | -24.9% | 16.3% | 41.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.79 | 1.60 |
| Avg | 0.76 | 1.54 |
| Low | 0.74 | 1.49 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 110.7% |
| Avg | - | 102.7% |
| Low | - | 96.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.